Breast cancer is a complex disease characterized by many morphological, clinical, and molecular features. For many years, this disease has been classified according to histopathologic criteria, known as the tumor, node, and metastasis (TNM) staging system. Clinical criteria that include immunohistochemical markers, such as the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2), provide a classification of breast cancer and dictates the optimal therapeutic approach for treatment. Different treatments are now available based on the molecular subtype of breast cancer, generally a combination of surgery, radiotherapy, chemotherapy, endocrine therapy, and/or targeted therapy. Their effectiveness is constantly increasing, allowing a reduction in mortality. Management of breast cancer with a multidisciplinary approach allows personalized care avoiding over treatment thereby avoiding the many early and late  psychological, physical, and social side effects.

This Annual Scientific Meeting is presented by the Canadian Society of Breast Imaging in partnership with The University of Ottawa's Department of Radiology, Radiation Oncology and Medical Physics. The ASM will present the progress made in the diagnosis and management of breast cancer using advanced imaging techniques. Presentations will cover updates in diagnosis, imaging, application of artificial intelligence in early breast cancer diagnosis and workup of breast cancer and its various clinical presentations. Topics of interest for trainees and technologists are included. Presentations will also include CSBI's Patient Engagement Working Group and the peer review process in breast imaging.

Dr. Supriya Kulkarni is the divisional head & associate professor, department of medical imaging at the University of Toronto.

Her clinical engagement is at University Health Network, Mount Sinai Hospital and the Women's College Hospital, University of Toronto, Canada for over 20 years in the subspecialty practice in Breast Imaging.

Dr. Kulkarni’s special focus is in teaching and education internationally and is a recipient of several teaching awards for contributing to cancer education.

She currently manages continuing professional development initiatives and faculty development for the breast division of the University of Toronto and national and international educational initiatives for Canadian Society of Breast imaging where she serves as a board member.

She serves in an advisory capacity pertaining to policy and quality for Ontario Health (OH) on provincial average and high risk screening programs and for the Canadian Association of Radiologists breast imaging guideline working group.

Dr. Kulkarni has worked to enhance diversity and opportunity to access breast screening for individuals from historically under-represented backgrounds, chairing the committee that developed the transgender screening policy with OH. She also provides mentorship and guidance to international trainees from varied backgrounds.